Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes

Archive ouverte

Valable, Samuel | Gérault, Aurélie | Lambert, Gaelle | Leblond, Marine | Anfray, Clement | Toutain, Jérôme | Bordji, Karim | Petit, Edwige | Bernaudin, Myriam | Pérès, Elodie A.

Edité par CCSD ; MDPI -

CERVOXY. International audience. Tumor hypoxia is known to limit the efficacy of ionizing radiations, a concept called oxygen enhancement ratio (OER). OER depends on physical factors such as pO2 and linear energy transfer (LET). Biological pathways, such as the hypoxia-inducible transcription factors (HIF), might also modulate the influence of LET on OER. Glioblastoma (GB) is resistant to low-LET radiation (X-rays), due in part to the hypoxic environment in this brain tumor. Here, we aim to evaluate in vitro whether high-LET particles, especially carbon ion radiotherapy (CIRT), can overcome the contribution of hypoxia to radioresistance, and whether HIF-dependent genes, such as erythropoietin (EPO), influence GB sensitivity to CIRT. Hypoxia-induced radioresistance was studied in two human GB cells (U251, GL15) exposed to X-rays or to carbon ion beams with various LET (28, 50, 100 keV/µm), and in genetically-modified GB cells with downregulated EPO signaling. Cell survival, radiobiological parameters, cell cycle, and ERK activation were assessed under those conditions. The results demonstrate that, although CIRT is more efficient than X-rays in GB cells, hypoxia can limit CIRT efficacy in a cell-type manner that may involve differences in ERK activation. Using high-LET carbon beams, or targeting hypoxia-dependent genes such as EPO might reduce the effects of hypoxia.

Suggestions

Du même auteur

M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma

Archive ouverte | Leblond, Marine | CCSD

CERVOXY. International audience

Nanosized zeolites as a gas delivery platform in a glioblastoma model

Archive ouverte | Anfray, Clement | CCSD

CERVOXY. International audience. Approaches able to counteract, at least temporarily, hypoxia, a well-known factor of resistance to treatment in solid tumors are highly desirable. Herein, we report the use of nanosi...

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma

Archive ouverte | Corroyer-Dulmont, Aurélien | CCSD

International audience

Chargement des enrichissements...